VERONICA DELANEY: Open Payments
NPI 1003457839 · VINCENNES, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$216 in 12 payments from 8 companies in 2025. Trend: 2023 $271 · 2024 $300 · 2025 $216
Food & beverage: $216
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $40 |
| Lilly USA, LLC | 2 | $40 |
| ABBVIE INC. | 2 | $38 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| Tris Pharma Inc | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| Amgen Inc. | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: TRELEGY ELLIPTA, VRAYLAR, JARDIANCE, Ozempic, Wegovy, MOUNJARO, Dyanavel XR, REXULTI.
Industry payments across IN — which companies pay providers there.
